Login / Signup

Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis.

Yoshiya TanakaTsutomu TakeuchiDaisuke KatoYuichiro KanekoMusashi FukudaDaisuke Miyatake
Published in: Modern rheumatology (2021)
Peficitinib was efficacious in adult Asian RA patients of all ages. Age, but not estimated glomerular filtration rate, was associated with serious infections and herpes zoster-related disease, demonstrating the importance of an appropriate RA treatment strategy in older patients.
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • end stage renal disease
  • ankylosing spondylitis
  • interstitial lung disease
  • patient reported